Experimental treatment could offer a safer, cheaper alternative to CAR T cell therapies for disorders such as lupus.

During animal development, cells divide and arrange themselves in a coordinated way, eventually forming the embryo.

Four days ahead of its July 7 PDUFA date, the U.S. FDA granted accelerated approval to Dizal (Jiangsu) Pharmaceutical Co. Ltd.’s sunvozertinib (DZD-9008), branded as Zegfrovy, for treating adults with ...

Aussie researchers have used CRISPR gene editing tools to “armor” chimeric antigen receptor (CAR) T cells to activate additional cancer-fighting proteins at the tumor site, enabling them to target ...

Cornell researchers have found a new and potentially more accurate way to see what proteins are doing inside living cells - using the cells' own components as built-in sensors.

Cornell researchers have found a new and potentially more accurate way to see what proteins are doing inside living ...